I have not made any purchases in my dynamic DCA strategy since April 23. $MAP (-0.09%) in my dynamic DCA strategy, and not for lack of desire. It is one of those companies that I consider interesting for the long term, with its solid dividends, but to benefit from a revaluation of the share price you should always buy below 2.90€.

Currently, I consider Mapfre's share price to be above its fair value based on its historical performance, the composition of its main shareholders and the general market context. After the publication of its quarterly results, the price has maintained a bullish tone that does not respond to a structural improvement of the business, but to a combination of cyclical factors and the technical momentum that has led the share to overcome recent resistance.

I prefer to stay on the sidelines as long as the share price remains above 2.90 euros. My investment strategy allows me to be patient and not enter at prices that I consider unattractive in terms of risk-return.

I am convinced that better opportunities to strengthen the position will come, and in the stock market, many times, knowing how to wait is also investing. For now, patience and vigilance.

--

Since April 23rd, I haven't made any additional purchases in $MAP (-0.09%) within my dynamic DCA strategy - and not for lack of interest. It's one of those companies I find attractive for the long term, thanks to its solid dividend yield, but to benefit from meaningful price appreciation, you need to consistently buy below €2.90.

At present, I believe Mapfre's share price is trading above its fair value when compared to its historical behavior, the profile of its major shareholders, and the current market environment. Following the release of its quarterly results, the stock has maintained an upward trend that, in my view, isn't driven by any structural improvement in the business, but rather by a combination of short-term factors and technical momentum that has pushed the price beyond recent resistance levels.

I prefer to stay on the sidelines while the share price remains above €2.90. My investment strategy allows me to be patient and avoid entering at levels I find unattractive in terms of risk-return.

I'm confident better opportunities will come to strengthen my position. In investing, sometimes the smartest move is to wait. For now, it's a matter of patience and close monitoring.

At the end of March 2025, I made the decision to begin my journey through the winding roads of investment. And as a novice investor, I did it hand in hand with a sector familiar to me: insurance.

For that reason, about 75% of my portfolio belongs to the sector.

My strong bet today is $2318 (-1.2%) a solid company affected by circumstances external to its activity. A $MAP (-0.09%) special affection and together with $ALV (+0.76%) stabilizers. $G (+0.27%) It underpins the portfolio and stabilizes it. $PHNX (-0.16%) distributes generous dividends without harming its business, and $SBRE (+2.05%) has a beastly potential, with a unique business.

Mostly Continental European companies, two British and one Chinese. The first four are general insurance companies with a strong focus on Property & Casualty. Phoenix Group is focused on life insurance and Sabre on premium motor insurance with strong underwriting of motorcycles.

Outside of insurance, an ETF in the defense and security sector such as $IVDF (+0.52%) as well as the Spanish $AMP (+2.52%) which is also closely linked to defense and security and has come out of a difficult situation on the right track.

My plan? To invest around 50€ per week in these stocks through a dynamic investment plan in Trade Republic. Each week I will vary the portion of investment I allocate to each position according to its evolution.

We'll see!